Renaissance Technologies
HUMA icon

Renaissance Technologies’s Humacyte HUMA Stock Holding History

Renaissance Technologies’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$57.1K Buy
+110,271
New +$70.6K ﹤0.01% 3073
2024
Q3 		– Sell
-600,300
Closed -$2.88M – 3682
2024
Q2 		$2.88M Buy
600,300
+524,600
+693% +$2.73M ﹤0.01% 1643
2024
Q1 		$235K Sell
75,700
-19,400
-20% -$65.2K ﹤0.01% 3175
2023
Q4 		$270K Sell
95,100
-12,400
-12% -$31.8K ﹤0.01% 3025
2023
Q3 		$315K Buy
107,500
+35,900
+50% +$119K ﹤0.01% 2908
2023
Q2 		$205K Buy
71,600
+23,900
+50% +$86.2K ﹤0.01% 3295
2023
Q1 		$147K Buy
47,700
+23,900
+100% +$68K ﹤0.01% 3376
2022
Q4 		$50K Sell
23,800
-184,200
-89% -$559K ﹤0.01% 3793
2022
Q3 		$678K Buy
208,000
+196,900
+1,774% +$755K ﹤0.01% 2730
2022
Q2 		$36K Sell
11,100
-36,000
-76% -$200K ﹤0.01% 4051
2022
Q1 		$333K Buy
47,100
+32,300
+218% +$188K ﹤0.01% 3423
2021
Q4 		$107K Buy
+14,800
New +$146K ﹤0.01% 3667

Other funds holding HUMA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Endowment Wealth Management
Endowment Wealth Management Appleton, Wisconsin $292M AUM 11.49% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Renaissance Technologies's HUMA Position: Q3 2026 in Review

Renaissance Technologies opened a new position in Humacyte (HUMA) in Q3 2026: 110,271 shares worth $57.1K. The stake represents ﹤0.01% of the portfolio and ranks #3073 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in HUMA as recently as Q2 2024.

Renaissance Technologies first reported a position in HUMA in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.88M in Q2 2024. 98 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

  • Renaissance Technologies held 110,271 shares of Humacyte worth $57.1K as of Q3 2026.
  • Humacyte was a new Renaissance Technologies position in Q3 2026.
  • Humacyte made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3073 holding.
  • Renaissance Technologies first reported a position in Humacyte in Q4 2021 and has held it in 12 quarters since.
  • Renaissance Technologies's Humacyte position peaked at $2.88M in Q2 2024.
  • 98 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.